SCHEMBL6857288

SCHEMBL6857288

CC(=O)[C@@H]1CCC2=CC(=O)C[C@H](C)[C@@]2(C)C1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 3/20 0.78
SMN1; SMN2 Q16637 6/20 0.43
CYP3A4 P08684 5/20 0.43
LMNA P02545 5/20 0.43
ALDH1A1 P00352 5/20 0.43
MAPT P10636 4/20 0.43
SERPINA6 P08185 4/20 0.43
SHBG P04278 4/20 0.43
HIF1A Q16665 3/20 0.43
MAPK1 P28482 3/20 0.43
CYP2C9 P11712 2/20 0.43
TSHR P16473 2/20 0.43
NR3C2 P08235 2/20 0.43
MEN1 O00255 2/20 0.43
NR3C1 P04150 2/20 0.43
ADORA3 P0DMS8 2/20 0.43
KMT2A Q03164 2/20 0.43
ABCB11 O95342 2/20 0.43
KDM4E B2RXH2 1/20 0.43
SLC22A2 O15244 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16188788 1.00 CYP2C19 (0.78) CYP2C19SMN1; SMN2CYP3A4LMNAALDH1A1
SCHEMBL24434436 0.89 CYP2C19 (0.73) CYP2C19SMN1; SMN2CYP3A4LMNAALDH1A1
Nootkatone SCHEMBL14137791 0.87 CYP2C19 (1.00) CYP2C19SMN1; SMN2CYP3A4LMNAALDH1A1
Nootkatone SCHEMBL309679 0.87 CYP2C19 (1.00) CYP2C19SMN1; SMN2CYP3A4LMNAALDH1A1
Nootkatone SCHEMBL335639 0.87 CYP2C19 (1.00) CYP2C19SMN1; SMN2CYP3A4LMNAALDH1A1
Nootkatone SCHEMBL110855 0.87 CYP2C19 (1.00) CYP2C19SMN1; SMN2CYP3A4LMNAALDH1A1
Nootkatone SCHEMBL10146951 0.87 CYP2C19 (1.00) CYP2C19SMN1; SMN2CYP3A4LMNAALDH1A1
Nootkatone SCHEMBL3276192 0.87 CYP2C19 (1.00) CYP2C19SMN1; SMN2CYP3A4LMNAALDH1A1
11,12-Epoxynootkatone SCHEMBL13588488 0.76 CYP2C19 (0.60) CYP2C19SMN1; SMN2CYP3A4LMNAALDH1A1
SCHEMBL15462827 0.76 CYP2C19 (0.60) CYP2C19SMN1; SMN2CYP3A4LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6787671-B2 FOR PRODUCTION OF ALDEHYDES, CARBOXYLIC ACIDS, ESTERS, OR KETONES VIA REACTION OF OSMIUM CATALYST AND PEROXYMONOSULFURIC ACID BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY 2004-09-07 US disclosed
US-20030149299-A1 Catalytic osmium-assisted oxidative cleavage of olefins BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY 2003-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030149299-A1 Catalytic osmium-assisted oxidative cleavage of olefins OXER1, OXSR1, AOX1 CYP2C19 1035/4885SMN1; SMN2 3725/4885CYP3A4 351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.